Emergent BioSolutions Inc. — Director's Dealing 2015

Sep 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-09-11

Reporting Person: Bailey Sue (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-11	Common Stock	M	1440	$8.43	Acquired	29940	Direct
2015-09-11	Common Stock	S	1440	$32.49	Disposed	28500	Direct
2015-09-11	Common Stock	M	4640	$8.76	Acquired	33140	Direct
2015-09-11	Common Stock	S	4640	$32.33	Disposed	28500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-11	Stock Option	$8.43	M	1440	Disposed	2017-06-13	Common Stock (1440)	Direct
2015-09-11	Stock Option	$8.76	M	4640	Disposed	2018-05-20	Common Stock (4640)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on June 14, 2007.

F2: Consists of an option granted under the company's stock incentive plan on May 21, 2008.